PROJECT PLAN Flashcards

1
Q

What is the mortality rate of pancreatic ductal adenocarcinoma (PDAC)?

A

> 90%

PDAC is known for its aggressive nature and poor prognosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

At what mean age are patients typically diagnosed with PDAC?

A

71 years

There is a noted increase in early onset cases in patients under 50.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the categories of PDAC management and treatment?

A
  • Surgically resectable cancer
  • Potentially resectable tumour
  • Metastatic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the overall survival rate for patients with resected PDAC after completing post-surgical chemotherapy?

A

40% (3 years), 20% (5 years)

These rates highlight the importance of effective post-surgical treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What factors contribute to the failure of treatment in PDAC?

A
  • Development of resistance
  • Heterogeneity of tumour cells
  • Tumour microenvironment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

True or False: Progress has been made in the early diagnosis and treatment of PDAC.

A

False

There has been little progress compared to other cancer types.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the significance of exhausted and senescent T lymphocytes in PDAC?

A

They are enriched in the tumour center and contribute to resistance to immune checkpoint inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What urgent need is identified in the management of PDAC?

A
  • Identify markers for favourable survival outcomes
  • Assess differences in tumour microenvironment based on age of onset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the main purpose of the project discussed?

A

Identify markers predictive for positive response to therapeutic regimes at diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the specific aims of the project?

A
  • A. Multivariate correlation of tumour microenvironment heterogeneity with therapeutic response and age onset
  • B. Assess the role of onset age in disease severity in vivo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What methodologies will be used to assess the immune profiling of the tumour microenvironment?

A
  • Multiplex in situ transcriptomics
  • Immunofluorescence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the Global Cancer Statistics 2020 ranking for PDAC?

A

14th most common cancer worldwide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What types of therapy are given to patients with borderline resectable PDAC?

A

Neoadjuvant therapy before surgical resection consideration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a major reason for dismal results in immune checkpoint inhibitor therapy in PDAC?

A

Highly immunosuppressive tumour microenvironment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the relationship between early onset pancreatic cancer and smoking?

A

Higher incidence in countries with high smoking rates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the two patient groups analyzed in the pilot study?

A
  • Resectable tumour followed by adjuvant therapy
  • Borderline resectable with neoadjuvant therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the hypothesis regarding tumours of different age onset?

A

They have different immune and mutation profiles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What specific immune markers will be analyzed in the spatial immune profile?

A
  • B cells (CD79a)
  • CD4 and CD8 T lymphocytes
  • T cell exhaustion markers (TCF1, PD1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the purpose of combining immunofluorescence and RNAscope?

A

To perform phenotypic and functional analysis of immune profiling and cytokine mRNA expression.

20
Q

What are the clinical outcome parameters analyzed in relation to immune profiles?

A
  • Relapse Rate (RR)
  • Disease Free Survival (DFS)
  • Overall Survival (OS)
21
Q

What preliminary findings suggest a correlation with improved overall survival in PDAC?

A

Percentage of cells expressing the T cell transcription factor TCF1 in the tumour centre.

22
Q

What are cytotoxic T lymphocytes?

A

A type of immune cell that kills cancer cells and infected cells.

23
Q

What is the significance of TCF1 and CD4 double-positive cells in cancer research?

A

They are associated with improved overall survival (OS) in patients.

24
Q

What does a Kaplan Meier curve illustrate?

A

Overall survival (OS) rates over time for different patient groups.

25
What does a high percentage of TCF1-positive cells indicate?
A significant association with improved OS.
26
What is the expected outcome of the study?
Identification of a panel of markers to assess at diagnosis for treatment response.
27
How does age influence the immune profile and tumor progression?
It may affect tumor mutation burden, immune profiles, and metastatic disease progression.
28
What is hypothesized about the age of onset of pancreatic cancer?
It is associated with a different pattern of mutation and immune profiles.
29
What are the two in vivo models used in the study?
1. Orthotopically transplanted mouse model with pancreatic cancer. 2. Spontaneous tumor development KPC mouse model.
30
What type of cells does the orthotopic model use?
A syngeneic PDAC cell line derived from the KP mouse model.
31
What is the significance of the KRAS mutation in the study?
It is a critical mutation in pancreatic cancer development.
32
What does the term 'mutational burden' refer to?
The total number of mutations within a tumor's genome.
33
Fill in the blank: The experimental set-up involves collaboration with _______ at Umeå University.
Prof. Jenny Persson
34
What is the role of the cytokines Ifng, Il8, Il6, and Il10 in the study?
They are analyzed for pro-inflammatory and anti-inflammatory profiles.
35
True or False: Preliminary data showed that older mice developed tumors at the same rate as younger mice.
False.
36
What is the purpose of whole genome sequencing in the study?
To assess the mutational burden of tumor cells.
37
What is the expected outcome regarding tissue-specific markers?
Define markers associated with more aggressive disease progression.
38
What are the strengths of the project?
Established methods, expertise in tumor biology, and access to bio-banked tissue material.
39
What risk involves insufficient patient material?
Focus on late disease onset and therapeutic outcome.
40
What is a significant gap of knowledge addressed by the project?
The lack of predictive markers for pancreatic ductal adenocarcinoma (PDAC).
41
What will identifying predictive and immune prognostic markers contribute to?
Refine histopathological analysis and patient stratification.
42
Which type of cancer is specifically mentioned in connection with the study?
Pancreatic ductal adenocarcinoma (PDAC).
43
What is the role of the postdoc candidate Vasileios Vardas?
To provide valuable expertise for the project.
44
Fill in the blank: The applicant has received funding from the _______.
Swedish Cancer Society
45
What is the purpose of the Visium analysis mentioned in the study?
To analyze tissue samples for immune profiling.
46
What does the term 'exhausted T cells' refer to?
T cells that have diminished function due to chronic stimulation.